Prostate Cancer

Prostate cancer is a malignancy of the prostate gland, and is one of the most common cancers in men. In most cases, these tumours are adenocarcinomas (cancers arising from mucus-producing glands), however it can also develop as sarcomas (cancers arising from bone or soft tissue), small cell carcinomas (cancers arising from the tissues that line organs) or neuroendocrine tumours of the prostate (tumours that develop from neuroendocrine cells that produce hormones and peptides).

The prostate is a walnut-shaped gland in the male reproductive system. It sits below the bladder, and in front of the rectum (end of the small bowel). The prostate is responsible for producing semen, a bodily fluid that acts as a vessel for sperm transport during ejaculation, and nourishment to keep the sperm alive outside of the body. It also has a small role in the urinary system, as the thin tube (ureter) that runs through the bladder to the penis is passed through the prostate.

Prostate cancers are most commonly found in men over 55 years of age. However, anyone with a prostate – including teenagers, transgender women, non-binary individuals,  and intersex people – can develop this disease at any age.

Treatment

If prostate cancer is detected, it will be staged and graded based on size, metastasis, and how the cancer cells look under the microscope. Staging and grading helps your doctors determine the best treatment for you.

Cancers can be staged using the TNM staging system:

  • T (tumour) indicates the size and depth of the tumour.
  • N (node) indicates whether the cancer has spread to nearby lymph nodes.
  • M (metastasis) indicates whether the cancer has spread to other parts of the body.

This system can also be used in combination with a numerical value, from stage 0-IV:

  • Stage 0: this stage describes cancer cells in the place of origin (or ‘in situ’) that have not spread to nearby tissue.
  • Stage I: cancer cells have begun to spread to nearby tissue. It is not deeply embedded into nearby tissue and had not spread to lymph nodes. This stage is also known as early-stage cancer.
  • Stage II: cancer cells have grown deeper into nearby tissue. Lymph nodes may or may not be affected. This is also known as localised cancer.
  • Stage III: the cancer has become larger and has grown deeper into nearby tissue. Lymph nodes are generally affected at this stage. This is also known as localised cancer.
  • Stage IV: the cancer has spread to other tissues and organs in the body. This is also known as advanced or metastatic cancer.

Cancers can also be graded based on the rate of growth and how likely they are to spread:

  • Grade I: cancer cells present as slightly abnormal and are usually slow growing. This is also known as a low-grade tumour.
  • Grade II: cancer cells present as abnormal and grow faster than grade-I tumours. This is also known as an intermediate-grade tumour.
  • Grade III: cancer cells present as very abnormal and grow quickly. This is also known as a high-grade tumour.

Once your tumour has been staged and graded, your doctor may recommend genetic testing, which analyses your tumour DNA and can help determine which treatment has the greatest chance of success. They will then discuss the most appropriate treatment option for you.

Treatment is dependent on several factors, including location, stage of disease and overall health.

Treatment options for prostate cancer may include:

  • Surgery to remove the prostate (prostatectomy), potentially including:
    • Retropubic prostatectomy.
    • Perineal prostatectomy.
  • Chemotherapy.
  • Radiation therapy.
  • Hormone therapy, such as androgen deprivation therapy (ADT).
  • Watch and wait.
  • Clinical trials.
  • Palliative care.

Prostate Cancer Treatment and Fertility

Treatment for prostate cancer may make in difficult to conceive a child. If fertility is important to you, discuss your options with your doctor and a fertility specialist prior to the commencement of treatment.

Risk factors

While the cause of prostate cancer remains unknown, the following factors may increase your risk of developing the disease:

  • Being over 55 years of age.
  • Having a family history of prostate cancer.
  • Having a family history of breast and/or ovarian cancer.
  • Having BRCA1 and/or BRAC2 genetic mutations.
  • Being if African American descent.

Not everyone with these risk factors will develop the disease, and some people who have the disease may have none of these risk factors. See your general practitioner (GP) if you are concerned.

Symptoms

Symptoms of prostate cancer may include:

  • Changes in urination, such as:
    • Polyuria.
    • Feeling like your bladder isn’t empty after urination.
    • Slow urine flow.
    • Weaker bladder.
    • Loss of bladder control.
  • Incontinence.
  • Blood in urine and/or semen.
  • Erectile dysfunction.
  • Pain when ejaculating.
  • Unexplained weight loss.
  • Bone pain.

Not everyone with the symptoms above will have cancer but see your general practitioner (GP) if you are concerned.

Diagnosis

If your doctor suspects you have prostate cancer, they may order the following tests to confirm the diagnosis and refer you to a specialist for treatment:

  • Physical examination.
  • Digital rectal examination (DRE).
  • Imaging tests, potentially including:
    • TRUS (transrectal ultrasound).
    • MRI (magnetic resonance imaging).
    • CT (computed tomography) scan.
  • Blood tests, such as to check your PSA level.
  • Biopsy.

References

Keep up with Rare Cancers Australia

Inside Rare is a monthly newsletter that shares the latest news, events and stories connecting the rare community.